✨ Health Notices
27 SEPTEMBER 2012
NEW ZEALAND GAZETTE, No. 120
3419
Product: Ropibam
Active Ingredient: Ropivacaine hydrochloride, anhydrous 7.5mg/mL equivalent to ropivacaine 6.62mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturers: L Molteni & C Dei F lli Alitti Societa di Esercizio SpA, Firenze, Italy
Haemopharm Biofluids S.R.L, Tovo di Sant’Agata, Italy
Product: Ropibam
Active Ingredient: Ropivacaine hydrochloride, anhydrous 10mg/mL equivalent to ropivacaine 8.83mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturers: L Molteni & C Dei F lli Alitti Societa di Esercizio SpA, Firenze, Italy
Haemopharm Biofluids S.R.L, Tovo di Sant’Agata, Italy
Product: Xanopan
Active Ingredients: Latanoprost 0.05mg/mL
Timolol maleate 6.83mg/mL equivalent to timolol 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Wintac Limited, Karnataka, India
Dated this 19th day of September 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go6136
New Zealand Public Health and Disability Act 2000
Primary Maternity Services Amendment Notice 2012
Pursuant to section 88 of the New Zealand Public Health and Disability Act 2000, the Crown issues the following notice.
Notice
- Title—(1) This notice is the Primary Maternity Services Amendment Notice 2012.
(2) In this notice, the Primary Maternity Services Notice 2007, which was published as a Supplement to the New Zealand Gazette, 13 April 2007, No. 41, page 1025, and became effective from 1 July 2007, is called the "principal notice".
-
Commencement—This notice comes into force on 1 October 2012.
-
Amendment—The principal notice is amended on page 1084 by revoking Schedule 1 and substituting the new Schedule 1 to this notice.
-
Transitional provision relating to implementation of amendment—(1) The default transitional provisions in clause A12 on page 1037 of the principal notice apply to this amendment.
(2) For the purposes of applying the default transitional provisions, the implementation date for this amendment is 1 October 2012.
Dated this 29th day of August 2012.
HON TONY RYALL, Minister of Health.
Schedule 1
Fees
1 Maternity LMC Antenatal Services (WM1007)
| Fees (GST Excl) | |
|---|---|
| (1) first and second trimester | |
| (a) full fee | 307.50 |
| (b) first partial fee | 179.00 |
| (c) last partial fee | 128.00 |
| (2) third trimester | |
| (a) full fee | 297.00 |
| (b) first partial fee | 128.00 |
| (c) last partial fee | 169.00 |
2 Maternity LMC Labour and Birth Services (WM1008)
| Fees (GST Excl) | |
|---|---|
| (1) labour and birth | |
| (a) first birth | 1,117.00 |
| (b) VBAC | 1,117.00 |
| (c) subsequent birth | 876.00 |
Next Page →
NZ Gazette 2012, No 120
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare19 September 2012
Medicines Act, New Medicines, Ropibam, Xanopan
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥 Primary Maternity Services Amendment Notice 2012
🏥 Health & Social Welfare29 August 2012
Maternity Services, Fees, Amendment, Schedule
- HON TONY RYALL, Minister of Health